Respiratory infections are caused by both bacteria and viruses located in the upper and lower respiratory tracts of patients. These infections produce many common clinical symptoms such as:
Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.
Innovative Gx Laboratories’ Respiratory Pathogen Panel (RPP) is a molecular diagnostic test that will rapidly identify a wide range of respiratory pathogens using both Polymerase Chain Reaction (PCR) and Reverse Transcription Polymerase Chain Reaction (RT PCR). Both PCR and RT-PCR technologies precisely identify the correct pathogen(s) present in the infection and will also detect antibiotic drug resistance contained in the pathogen.
Helps improve clinical confidence and decrease patient risks
The Innovative Gx Laboratories’ Molecular Respiratory Pathogen Test (RPP) quickly identifies pathogens and detects potential antibiotic resistance so that effective treatment can begin sooner.
